On Friday, ICU Medical, Inc. (NASDAQ: ICUI) opened lower -3.69% from the last session, before settling in for the closing price of $120.55. Price fluctuations for ICUI have ranged from $78.28 to $185.63 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
It was noted that within the last five years, the titan of the Healthcare sector saw sales topped by 13.31%. Company’s average yearly earnings per share was noted -28.49% at the time writing. With a float of $21.24 million, this company’s outstanding shares have now reached $24.14 million.
The extent of productivity of a business whose workforce counts for 14000 workers is very important to gauge.
ICU Medical, Inc. (ICUI) Insider and Institutional Ownership
A key investor’s attitude towards the stock of the Medical Instruments & Supplies industry is another important factor to consider. The insider ownership of ICU Medical, Inc. is 12.82%, while institutional ownership is 93.53%. The most recent insider transaction that took place on May 30 ’24, was worth 1,303,485. In this transaction Chief Operating Officer of this company sold 12,539 shares at a rate of $103.95, taking the stock ownership to the 0 shares. Before that another transaction happened on May 16 ’24, when Company’s Director sold 300 for $104.95, making the entire transaction worth $31,484. This insider now owns 2,129 shares in total.
ICU Medical, Inc. (ICUI) Latest Financial update
If we go through the results of last quarter, which was made public on 3/31/2024, the company posted 1.88 earnings per share (EPS) for the quarter, besting the agreed prediction (set at 1.6) by 0.28. Wall Street market experts anticipate that the next fiscal year will bring earnings of 1.32 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -28.49% per share during the next fiscal year.
ICU Medical, Inc. (NASDAQ: ICUI) Trading Performance Indicators
Check out the current performance indicators for ICU Medical, Inc. (ICUI). In the past quarter, the stock posted a quick ratio of 1.08. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.25. Likewise, its price to free cash flow for the trailing twelve months is 33.23.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.46, a number that is poised to hit 1.00 in the next quarter and is forecasted to reach 6.64 in one year’s time.
Technical Analysis of ICU Medical, Inc. (ICUI)
The latest stats from [ICU Medical, Inc., ICUI] show that its last 5-days average volume of 0.41 million was superior to 0.25 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 78.11%. Additionally, its Average True Range was 4.32.
During the past 100 days, ICU Medical, Inc.’s (ICUI) raw stochastic average was set at 79.92%, which indicates a significant increase from 65.07% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 38.06% in the past 14 days, which was lower than the 39.71% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $104.40, while its 200-day Moving Average is $102.48. Now, the first resistance to watch is $119.42. This is followed by the second major resistance level at $122.73. The third major resistance level sits at $125.14. If the price goes on to break the first support level at $113.70, it is likely to go to the next support level at $111.29. The third support level lies at $107.98 if the price breaches the second support level.
ICU Medical, Inc. (NASDAQ: ICUI) Key Stats
There are currently 24,366K shares outstanding in the company with a market cap of 2.83 billion. Presently, the company’s annual sales total 2,259 M according to its annual income of -29,660 K. Last quarter, the company’s sales amounted to 566,660 K and its income totaled -39,470 K.
